ArticleJTCVS open2026
Does donor age older or younger than 70 years influence lung transplantation outcomes?
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: For lung transplantation (LTx) we are lacking long-term outcomes using older donors. The aim of our study was to evaluate our cohort regarding the use of donors aged 70 years and older compared with those younger than age 70 years after LTx. Methods: In a retrospective single-center study including all LTx procedures performed between 2006 and 2024 (n = 689) we compared short- and long-term mortality and retransplantation between groups based on donor age older or younger than 70 years. Results: Recipients with older donors (n = 75 [10.9%]) were older (60.4 ± 9.5 years vs 52.7 ± 14.1 years; Conclusions: This study shows that 1-year survival using grafts from donors older than age 70 years is comparable to those of younger donors, but long-term survival is inferior, which indicates that grafts from older donors should be used in selected patients undergoing LTx.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.